CTI LIFE SCIENCES FUND
CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences currently manage $345 million of assets.
CTI LIFE SCIENCES FUND
Industry:
Clinical Trials Life Science Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
514 787 1620
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-10 | Domain Therapeutics | CTI Life Sciences Fund investment in Series A - Domain Therapeutics | 39 M EUR |
| 2022-04-25 | Epitopea | CTI Life Sciences Fund investment in Seed Round - Epitopea | 10.3 M GBP |
| 2020-10-07 | Phenomic AI | CTI Life Sciences Fund investment in Seed Round - Phenomic AI | 6 M USD |
| 2020-08-01 | Find therapeutics | CTI Life Sciences Fund investment in Seed Round - Find therapeutics | N/A |
| 2020-06-08 | Phenomic AI | CTI Life Sciences Fund investment in Seed Round - Phenomic AI | 3 M EUR |
| 2020-03-06 | Vaxcyte | CTI Life Sciences Fund investment in Series D - Vaxcyte | 110 M USD |
| 2018-06-18 | Phenomic AI | CTI Life Sciences Fund investment in Seed Round - Phenomic AI | 2 M USD |
| 2017-10-05 | Visterra | CTI Life Sciences Fund investment in Series C - Visterra | 23.6 M USD |
| 2017-07-27 | PreciThera | CTI Life Sciences Fund investment in Series A - PreciThera | 36 M CAD |
| 2017-06-27 | PHEMI | CTI Life Sciences Fund investment in Series B - PHEMI | 10 M USD |